Blood Cancer

Novartis, Jakavi, blood cancer, awareness campaigns, myeloproliferative neoplasms

Novartis commissions art exhibition to raise awareness of rare blood cancers

Anika Sharma

Novartis has taken a creative approach to raise awareness about rare blood cancers, specifically myeloproliferative neoplasms (MPNs), which impact approximately ...

Bristol Myers Squibb, Cellares, CAR-T Therapy, Blood cancer, Abecma, Breyanzi, cell and gene therapy

Bristol Myers Squibb’s Bold Robotic Alliance with Cellares for Advanced CAR-T Production

Anika Sharma

In the realm of cutting-edge cell therapy, where innovation is the heartbeat and the promise of transformative treatments is the ...

Karyopharm Cuts 20% of Staff as Xpovio Fails

Karyopharm reduces employees by 20% as Xpovio sales for blood cancer remain stagnant

SG Tylor

Source – Karyopharm Therapeutics Karyopharm Therapeutics, faced with stagnant sales of its only approved product, Xpovio (selinexor), has announced a ...

Second-Line Treatment of Multiple Myeloma Current and Future Options

Second-line treatment of multiple myeloma: current choices and future prospects

SG Tylor

This blog will discuss the second-line treatment of multiple myeloma, a blood cancer that affects antibody-producing plasma cells. Multiple myeloma ...

The Definitive Insight into Stem Cell Transplant in the USA

Stem Cell Transplant: A Definitive Insight

SG Tylor

Introduction Stem cell transplant, also known as bone marrow transplant, is a procedure that can save the lives of people ...

A Closer Look: Demystifying Myelofibrosis Symptoms


SG Tylor

Introduction: Myelofibrosis symptoms Myelofibrosis is a rare and serious blood cancer that affects the bone marrow, the soft tissue inside ...

Decoding Myelofibrosis Treatment: What You Need to Know

Understanding Myelofibrosis Treatment: What You Need to Know

SG Tylor

Introduction: Myelofibrosis Treatments In this article, we will discuss some of the most common Myelofibrosis treatments and what to expect ...